ANIP   $60.405  -1.06% Market Closed After Close 60.38 -0.04%

ANI Pharmaceuticals Inc
Total Cash 247.05M
totalCashPerShare 12.658
EBITDA 107.97M
Total Debt 289.92M
quickRatio 2.951
currentRatio 3.968
Total Revenue 538.95M
debtToEquity 60.324
Revenue/Share 28.241
ROA 0.03384
ROE 0.05904
grossProfits
freeCashflow 82.53M
operatingCashflow 112.59M
earningsGrowth
revenueGrowth 0.184
grossMargins 0.61337
ebitdaMargins 0.20033
operatingMargins 0.0654
profitMargins 0.05012
enterpriseValue 1.21B
forwardPE 12.139004
floatShares 15.91M
sharesOutstanding 21.03M
sharesShort 2.42M
sharesShortPriorMonth 309.40K
dateShortInterest
sharesPercentSharesOut 0.12%
heldPercentInsiders 0.11%
heldPercentInstitutions 0.84%
Short Ratio help_outline 5.74%
shortPercentOfFloat 0.15%
impliedSharesOutstanding
bookValue 23.311
Price To Book help_outline 2.51
earningsQuarterlyGrowth
netIncomeToCommon 22.93M
trailingEps 1.19%
forwardEps 4.82%
enterpriseToEbitda 11.20
lastDividendValue
lastDividendDate
currentQuarterEstimate 1.08 3Q 2024
institutionsCount 296
lastUpdated Sept. 16, 2024, 11:57 a.m.